Document:

EX-10.1

 Exhibit 10.1 

RESTRICTED STOCK UNIT GRANT AGREEMENT 

This GRANT AGREEMENT (this “Agreement”), dated as of
                    , 20         (the “Grant Date”), is between IASIS Healthcare Corporation
( “IASIS” or the “Company”) and the undersigned (the “Participant”). 
 WHEREAS, the
Board of Directors of the Company (the “Board”) desires to grant to the Participant the number of RSUs on the terms and conditions set forth herein. 

NOW, THEREFORE in consideration the promises and the mutual covenants hereinafter set forth, the parties hereto hereby agree as follows: 

Section 1. Definitions. 

(a) “Affiliate” shall mean the Company and any of its direct or indirect subsidiaries. 

(b) “Change in Control” shall mean any transactions or series of related transactions pursuant to which any Person (as defined
in Section 13(d)(3) or 14(d)(2) of the Exchange Act of 1934) or “group” of Persons (as defined in Section 13(d) of the Exchange Act), (other than TPG Partners IV, LP and the other parties to the operating agreement of IASIS
Investment LLC, a Delaware limited liability company or their respective affiliates), in the aggregate, directly or indirectly, acquires beneficially or of record, (i) equity of a Designated Person possessing the voting power to elect a
majority of the Designated Person’s governing body (whether by merger, consolidation, reorganization, combination, sale or transfer of equity, stockholder or voting agreement, proxy, power of attorney or otherwise) or (ii) all or
substantially all of a Designated Person’s assets. Notwithstanding the foregoing, in no event will a Change in Control occur as a result of the initial public offering of the Company’s shares of common stock or any secondary offering to
the public. 
 (c) “Code” shall mean the Internal Revenue Code of 1986, as amended. 

(d) “Common Stock” shall mean the ordinary shares of the Company, par value US $0.01 per share. 

(e) “Cause” shall mean, when used in connection with the termination of a Participant’s Employment, the termination of
the Participant’s Employment by the Company or an Affiliate on account of (i) dishonesty in the performance of such Participant’s duties; (ii) the Participant’s willful misconduct in connection with such Participant’s
duties or any act or omission which is materially injurious to the financial condition or business reputation of the Company or any of its subsidiaries or affiliates; (iii) a breach by a Participant of the Participant’s duty of loyalty to
the Company and its Affiliates; (iv) the Participant’s unauthorized removal from the premises of the Company or Affiliate of any document (in any medium or form) relating to the Company or an Affiliate or the customers of the Company or an
Affiliate; or (v) the commission by the Participant of any felony or other serious crime involving moral turpitude. Any rights the Company or an Affiliate may have hereunder in respect of the events giving rise to Cause shall be in addition to
the rights the Company or Affiliate may have under any other agreement with the Participant or at law or in equity. If, subsequent to a Participant’s termination of Employment, it is discovered that such Participant’s Employment could have
been terminated for Cause, the Participant’s Employment shall, at the election of the Board, in its sole discretion, be deemed to have been terminated for Cause retroactively to the date the events giving rise to Cause occurred. 

(f) “Designated Person” shall mean IASIS Investment LLC and the Company. 

 (g) “Employment” shall mean employment with the Company or any Affiliate and
shall include the provision of services as a director or consultant for the Company or any Affiliate. “Employed” shall have correlative meanings. 

(h) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

(i) “Fair Market Value” shall mean, as of any date, the value of shares of Common Stock, determined as follows: (a) if
the shares of Common Stock are listed on one or more established stock exchanges or national market systems, including without limitation, The New York Stock Exchange and The Nasdaq Global Market, the closing sales price for such shares (or the
closing bid, if no sales were reported) of Common Stock as quoted on the principal exchange or system on which the shares of Common Stock are listed (as determined by the Board) on the date of determination (or, if no closing sales price or closing
bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Board deems reliable; (b) if the shares of Common
Stock are regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, the closing sales price for such shares as quoted on such system or by such securities dealer on the date of
determination, but if selling prices are not reported, the mean between the high bid and low asked prices for the shares of Common Stock on the date of determination (or, if no such prices were reported on that date, on the last date such prices
were reported), as reported in The Wall Street Journal or such other source as the Board deems reliable; or (c) in the absence of an established market for the shares Common Stock of the type described in (a) and (b), above, as determined
by the Board in good faith, consistent with the requirements of Section 409A of the Code, to the extent applicable. 
 (j) A
“Public Market” for the Common Stock shall be deemed to exist for purposes of the Plan if the Common Stock is registered under Section 12(b) or 12(g) of the Exchange Act and trading regularly occurs in such Common Stock in, on
or through the facilities of securities exchanges and/or inter-dealer quotation systems in the United States (within the meaning of Section 902(n) of the Securities Act) or any designated offshore securities market (within the meaning of Rule
902(a) of the Securities Act). 
 Section 2. Grant of Units. 

Effective as of the Grant Date, the Company shall grant to the Participant, subject to Section 3 hereof,
                     RSUs, which shall represent the right to receive cash or shares of Common Stock, as determined by the Board in its sole
discretion, upon settlement (the “Grant”). 
 Section 3. Vesting and Settlement. 

(a) The Grant shall vest in full on the third anniversary of the Grant Date (a “Vesting Date”), subject to the Participant
continuing to actively and without interruption remain Employed through the Vesting Date. 
 (b) Upon vesting, subject to this
Section 3, the Participant shall have the right to receive a number of shares of Common Stock corresponding to the number shares of Common Stock underlying the Grant. As soon as reasonably practicable and in any event no later than the
thirtieth (30th) day following the Vesting Date, the Company shall transfer to the Participant, in full and complete satisfaction of all of the obligations of the Company and the rights of
the Participant in respect of such RSUs, a number of shares of Common Stock, registered in the Participant’s name, equal to the number of such RSUs that are settled on and as of such date (the “Settlement Date”). (Except as
otherwise provided herein, on or prior to the Settlement Date, the Participant shall remit to the Company an amount in cash, by wire transfer of immediately available funds, certified check or such other method as the Company shall determine
sufficient to satisfy any applicable employment taxes and any U.S. federal, state and local and non-U.S. withholding requirements. The Company may determine to satisfy any such employment tax and/or withholding obligations through net settlement,
but is under no obligation to do so.) 

 (c) The Company may, in its sole discretion, in lieu of delivering shares of Common Stock in
settlement of the Vested RSUs pursuant to Section 3(b), elect to pay cash for the shares of Common Stock that would otherwise have been delivered on the Settlement Date, less applicable employment taxes and withholding, at a price per share of
Common Stock equal to the Fair Market Value as of the Settlement Date. 
 (d) Notwithstanding the forgoing, all RSUs will vest in full upon
the consummation of a Change in Control (such date also a “Vesting Date”), subject to the Participant continuing to actively and without interruption remain Employed through the date such Change in Control is consummated. 

Section 4. Termination of Services. 

(a) Upon termination of the Participant’s Employment for any reason, all of the Participant’s unvested RSUs shall immediately be
forfeited and cancelled for no consideration as of the Participant’s date of termination of Employment and without any further action taken by any party. 

Section 5. Representations, Warranties and Acknowledgments of the Participant. 

The Participant hereby represents and warrants to the Company that (i) the Participant has taken all action necessary for the
authorization, execution and delivery of this Agreement and the performance of all obligations of the Participant hereunder and no further approval or authorization is required, (ii) this Agreement, assuming due authorization, execution and
delivery by the other parties hereto, constitutes valid and legally binding obligations of the Participant, enforceable against the Participant in accordance with the terms of this Agreement, subject to laws of general application relating to
bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies, and (iii) in the event that the RSUs are settled in shares of Common Stock, the Participant shall
execute and become party to, and agree to be bound by, the Management Stockholders’ Agreement to the extent Participant has not previously done so and the Management Stockholders’ Agreement has not by its terms terminated or expired. 

Section 6. Execution of Documentation. 

The Participant hereby agrees to validly execute all proper documentation provided to the Participant by the Company or otherwise in connection
with this Agreement (including this Agreement) in a timely manner (as determined by the Company). 
 Section 7. Certain
Adjustments.  
 (a) Increase or Decrease in Issued Shares Without Consideration. Subject to any required action by the
stockholders of the Company, in the event of any increase or decrease in the number of issued shares of Common Stock resulting from a subdivision or consolidation of shares of Common Stock or the payment of a stock dividend (but only on the shares
of Common Stock), or any other increase or decrease in the number of such shares effected without receipt of consideration by the Company, the Board shall make such adjustments with respect to the number of shares of Common Stock subject to RSUs
granted under this Agreement as the Board may, in its absolute discretion, consider appropriate to prevent the enlargement or dilution of rights. 

(b) Certain Mergers. Subject to any required action by the stockholders of the Company, in the event that the Company shall be the
surviving corporation in any merger or consolidation (except a merger or consolidation as a result of which the holders of shares of Common Stock receive securities of another corporation), the RSUs outstanding on the date of such merger or
consolidation shall pertain to and apply to the securities that a holder of the number of shares of Common Stock subject to any such RSU would have received in such merger or consolidation (it being understood that if, in connection with such
transaction, the stockholders of the Company retain their shares of Common Stock and are not entitled to any additional or other consideration, the RSUs shall not be affected by such transaction). 

 (c) Certain Other Transactions. In the event of (i) a dissolution or liquidation of
the Company, (ii) a sale of all or substantially all of the Company’s assets, (iii) a merger or consolidation involving the Company in which the Company is not the surviving corporation or (iv) a merger or consolidation involving
the Company in which the Company is the surviving corporation but the holders of shares of Common Stock receive securities of another corporation and/or other property, including cash, the Board shall, in its absolute discretion, have the power to
provide for the exchange of each RSU outstanding immediately prior to such event (whether or not then exercisable) for RSUs on some or all of the property for which the stock underlying such RSUs are exchanged and, incident thereto, make an
equitable adjustment, as determined by the Board, to the number or kind of securities or amount of property subject to the RSUs and/or, if appropriate, cancel, effective immediately prior to such event, some or all of the outstanding RSUs (whether
or not vested) and in full consideration of such cancellation pay to the Participant an amount in cash, with respect to each underlying share of Common Stock, equal to the value, as determined by the Board in its sole discretion, of securities
and/or property (including cash) received by such holders of shares of Common Stock as a result of such event, as the Board may consider appropriate to prevent dilution or enlargement of rights; provided, however, that such
cancellation and payment shall either be exempt from or comply with the requirements of Section 409A of the Code. 
 (d) Other
Changes. In the event of any change in the capitalization of the Company or a corporate change other than those specifically referred to herein, the Board shall, in its absolute discretion, make such adjustments in the number and kind of share
of Common Stock or other securities subject to RSUs outstanding on the date on which such change occurs as the Board considers appropriate to prevent dilution or enlargement of rights. 

Section 8. Integration. 

This Agreement, together with any other documents referred to herein or delivered pursuant hereto, which form a part hereof, contain the entire
understanding of the parties with respect to its subject matter and there are no restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set
forth in such documents. This Agreement supersedes all prior agreements and understandings between the parties with respect to its subject matter. 

Section 9. Counterparts. 

This Agreement may be executed by the parties in any number of counterparts, each of which shall be deemed an original, but all of which shall
constitute one and the same agreement. A facsimile of a signature or a signature delivered in portable document (“.pdf”) format via email will be deemed to be, and have the effect of, an original signature. 

Section 10. Successors and Assigns. 

(a) This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the
Participant. This Agreement shall inure to the benefit of and shall be enforceable by the Participant and the Participant’s legal representatives. 

(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. 

(c) Nothing in this Agreement, express or implied, is intended to or shall confer upon any person other than the parties hereto, and their
respective heirs, legal representatives, successors and permitted assigns, any rights, benefits, or remedies of any nature whatsoever under or by reason of this Agreement. 

 Section 11. Governing Law. 

This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without regard to the
provisions thereof governing conflict of laws. 
 Section 12. Amendment and Waiver. 

The provisions of this Agreement may be amended and waived only with the prior written consent of the Company and the Participant and no course
of conduct or failure or delay in enforcing the provisions of this Agreement shall be construed as a waiver of such provisions or affect the validity, binding effect or enforceability of this Agreement or any provision hereof. 

Section 13. Rights as Stockholders. 

The Participant shall not have any rights as a stockholder with respect to any shares of Common Stock covered by or relating to the RSUs
granted pursuant to this Agreement until the date the Participant becomes the registered owner of such shares, if any. Except as otherwise expressly provided in Section 7 hereof, no adjustment to the RSUs shall be made for dividends or other
rights for which the record date occurs prior to the date such stock certificate is issued. 
 Section 14. Descriptive Headings.

 The descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its
duly authorized officer, and the Participant has or is deemed to have executed this Agreement, effective as of the date first written above. 
  

			
	IASIS Healthcare Corporation
		
	By:	 	 
	Name:	 	
	Title:	 	
	
	PARTICIPANT:
	
	 
	Name:EX-10.2

 Exhibit 10.2 

STOCK OPTION GRANT AGREEMENT 

(Non-Qualified Stock Options) 

(Vesting upon Change in Control) 

THIS STOCK OPTION GRANT AGREEMENT is made as of this
                , 20         between IASIS Healthcare Corporation (“Company”) and the undersigned (the
“Participant”). 
 WHEREAS, the Company has adopted and maintains the IASIS Healthcare Corporation 2004 Stock Option Plan
(“Plan”) to promote the interests of the Company and its Affiliates and stockholders by providing the Company’s key employees and others with an appropriate incentive to encourage them to continue in the employ of and provide
services to the Company or its Affiliates and to improve the growth and profitability of the Company; 
 WHEREAS, the Plan provides for the
Grant to Participants in the Plan of Non-Qualified Stock Options to purchase shares of Common Stock of the Company. 
 NOW, THEREFORE, in
consideration of the premises and the mutual covenants hereinafter set forth, the parties hereto hereby agree as follows: 
 1. Grant of
Options. Pursuant to, and subject to, the terms and conditions set forth herein and in the Plan, the Company hereby grants to the Participant a NON-QUALIFIED STOCK OPTION (“Option”) with respect to that number of shares of
Common Stock of the Company indicated on the Option Grant Statement attached hereto as Exhibit A. 
 2. Grant Date. The Grant
Date of the Option hereby granted is                  (“Grant Date”). 

3. Incorporation of Plan. All terms, conditions and restrictions of the Plan are incorporated herein and made part hereof as if stated
herein. If there is any conflict between the terms and conditions of the Plan and this Agreement, the terms and conditions of this Agreement shall govern. All capitalized terms used and not defined herein shall have the meaning given to such terms
in the Plan. 
 4. Exercise Price. The exercise price of each share underlying the Option hereby granted is
$            . 
 5. Vesting Date. 

(a) The Option shall vest and become exercisable with respect to twenty-five percent (25%) of the shares underlying the Option on each of
the first four anniversaries of the Grant Date (each such anniversary, a “Vesting Date”) subject to the Participant continuing to actively and without interruption remain Employed through each such Vesting Date. 

(b) Notwithstanding anything to the contrary herein, any portion of the Option that is not vested and exercisable as of immediately prior to a
Change in Control and that has not expired shall immediately vest and become exercisable as of such Change in Control. 

 6. Expiration Date; Net Exercise. Subject to the provisions of the Plan, the Option or any
portion thereof which has not become exercisable pursuant to Section 5 of this Agreement (taking into account any acceleration of exercisability as provided therein) shall expire on the earlier of (i) the date the Participant’s
Employment is terminated for any reason or (ii) the tenth anniversary of the Grant Date. Subject to the provisions of the Plan, with respect to any Option or any portion thereof which has become exercisable, the Option (or portion thereof)
shall expire on the earlier of: (i) one year after the Date of Termination of the Participant’s Employment on account of death or Disability, by the Participant for Good Reason or by the Company without Cause or as a result of the
Company’s election not to extend the term of the Participant’s effective employment agreement, if any, (ii) the commencement of business on the date the Participant’s Employment is, or is deemed to have been, terminated for
Cause; (iii) 90 days after the date the Participant’s Employment is terminated by the Participant without Good Reason or as a result of the non-renewal of the term by the Participant of the Participant’s effective employment
agreement, if any; or (iv) the tenth anniversary of the Grant Date. During the one-year period described in clause (i) above, the Participant shall be permitted to exercise the Option on a net basis (e.g., by satisfying the exercise price
and minimum statutory withholding tax obligations by having withheld a number of Option shares that have a fair market value equal to such obligations). 

7. Construction of Agreement. Any provision of this Agreement (or portion thereof) which is deemed invalid, illegal or unenforceable in
any jurisdiction shall, as to that jurisdiction and subject to this section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining provisions thereof in such jurisdiction or
rendering that or any other provisions of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is considered excessive, such covenant shall
be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this Agreement by the Company shall be implied by
the Company’s forbearance or failure to take action. 
 8. Delays or Omissions. No delay or omission to exercise any right, power
or remedy accruing to any party hereto upon any breach or default of any party under this Agreement, shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit,
consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party or any provisions or conditions of this Agreement, shall be in writing and shall be effective
only to the extent specifically set forth in such writing. 
 9. Limitation on Transfer. During the lifetime of the Participant, the
Option shall be exercisable only by the Participant. The Option shall not be assignable or transferable other than by will or by the laws of descent and distribution. All shares of Common Stock obtained pursuant to the Option granted herein shall
not be transferred except as provided in the Plan and, where applicable, the Management Stockholders’ Agreement. 
 10.
Integration. This Agreement, and the other documents referred to herein or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to its subject matter. There are no restrictions,
agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein and in the Plan. This Agreement, including without limitation the Plan, supersedes all
prior agreements and understandings between the parties with respect to its subject matter. 
 11. Counterparts. This Agreement may be
executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The Company’s authorized person may execute this Agreement using a facsimile signature. 

12. Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware
(United States of America) without regard to the provisions governing conflict of laws. 

 13. Participant Acknowledgment. The Participant hereby acknowledges receipt of a copy of
the Plan. The Participant hereby acknowledges that all decisions, determinations and interpretations of the Board in respect of the Plan, this Agreement and the Option shall be final and conclusive. The Participant further acknowledges that, prior
to the existence of a Public Market, no exercise of the Option or any portion thereof shall be effective unless and until the Participant has executed the Management Stockholders’ Agreement and the Participant hereby agrees to be bound thereby.

 IN WITNESS WHEREOF, the Company has caused this Agreement to be duly executed by its duly
authorized officer and said Participant has hereunto signed this Agreement on his own behalf, thereby representing that he has carefully read and understands this Agreement, the Plan and the Management Stockholders’ Agreement as of the day and
year first written above. 
  

			
	IASIS Healthcare Corporation
		
	By:	 	 
	Name:	 	
	Title:	 	
	
	 
	
	 Print Name and Mailing Address:

	
	 
	 
	 

 Exhibit A 

Option Grant Statement 
  

			
	Name	  	Number of Shares

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00230-of-00352.parquet"}]]